This website uses cookies to enhance your browsing experience, improve site performance, and gather analytics. By selecting 'Accept,' you consent to these cookies as described in our Privacy Policy.

Fitostimoline Vaginal Pessaries in Women With Hysterectomy. Randomized, Perspective, Monoscentric Study.

Sponsored by University of Milan

About this trial

Last updated 4 years ago

Study ID

Fitostimoline pessaries

Status

Unknown status

Type

Observational

Placebo

No

Accepting

18-75 Years
30 to 80 Years
Female
Female

Trial Timing

Ended 4 years ago

What is this trial about?

Clinical evaluation of Fitostimoline vaginal pessaries in the treatment of hysterectomy. An observational, randomized, perspective study performed on 60 women where 30 women are treated with fitostimoline pessaries and 30 women are treated with the standard of care.

What are the participation requirements?

Yes

Inclusion Criteria

- patient aged between 35 and 80 years

- patient undergoing hysterectomy

- Willingness to understand the procedures and aims of the study

No

Exclusion Criteria

- Anamnestic or clinical data of metabolic or endocrine diseases (such as uncontrolled diabetes mellitus) or any other local and / or systemic pathology potentially able to interfere with the study parameters;

- Concomitant treatment with antibiotics / antiseptics, NSAIDs, analgesics (excl. Paracetamol)

- Non-therapeutic use of psychoactive substances;

- Abuse of drugs and / or alcohol / smoking;

- Neurological disorders or psychiatric conditions potentially capable of affecting the validity of the consent and / or compromising the patient's adherence to the study procedures;

- Known allergy, hypersensitivity or intolerance to the constituents of the preparations under study;

- Any condition, medical or otherwise, that could significantly reduce the possibility of obtaining reliable data, achieving the objectives of the study, perfecting its completion;

- Presumption of poor reliability or collaboration;

- Treatment with any preparation in the last 30 days prior to the start of the study;

- Patients already enrolled in this study;

- Center staff directly involved in the study and close relatives

Locations

Location

Status

Recruiting